Identification of Phosphorylation Sites in the Nucleocapsid Protein (N Protein) of SARS-coronavirus
Overview
Authors
Affiliations
After decoding the genome of SARS-coronavirus (SARS-CoV), next challenge is to understand how this virus causes the illness at molecular bases. Of the viral structural proteins, the N protein plays a pivot role in assembly process of viral particles as well as viral replication and transcription. The SARS-CoV N proteins expressed in the eukaryotes, such as yeast and HEK293 cells, appeared in the multiple spots on two-dimensional electrophoresis (2DE), whereas the proteins expressed in showed a single 2DE spot. These 2DE spots were further examined by Western blot and MALDI-TOF/TOF MS, and identified as the N proteins with differently apparent p values and similar molecular mass of 50 kDa. In the light of the observations and other evidences, a hypothesis was postulated that the SARS-CoV N protein could be phosphorylated in eukaryotes. To locate the plausible regions of phosphorylation in the N protein, two truncated N proteins were generated in and treated with PKCα. The two truncated N proteins after incubation of PKCα exhibited the differently electrophoretic behaviors on 2DE, suggesting that the region of 1-256 aa in the N protein was the possible target for PKCα phosphorylation. Moreover, the SARS-CoV N protein expressed in yeast were partially digested with trypsin and carefully analyzed by MALDI-TOF/TOF MS. In contrast to the completely tryptic digestion, these partially digested fragments generated two new peptide mass signals with neutral loss, and MS/MS analysis revealed two phosphorylated peptides located at the "dense serine" island in the N protein with amino acid sequences, GFYAEGSRGGSQASSRSSSR and GNSGNSTPGSSRGNSPARMASGGGK. With the PKCα phosphorylation treatment and the partially tryptic digestion, the N protein expressed in released the same peptides as observed in yeast cells. Thus, this investigation provided the preliminary data to determine the phosphorylation sites in the SARS-CoV N protein, and partially clarified the argument regarding the phosphorylation possibility of the N protein during the infection process of SARS-CoV to human host.
Production and Characterization of a SARS-CoV-2 Nucleocapsid Protein Reference Material.
Stocks B, Thibeault M, LAbbe D, Stuible M, Durocher Y, Melanson J ACS Meas Sci Au. 2023; 2(6):620-628.
PMID: 36785774 PMC: 9662649. DOI: 10.1021/acsmeasuresciau.2c00050.
Tugaeva K, Sysoev A, Kapitonova A, Smith J, Zhu P, Cooley R J Mol Biol. 2022; 435(2):167891.
PMID: 36427566 PMC: 9683861. DOI: 10.1016/j.jmb.2022.167891.
Garza-Dominguez R, Torres-Quiroz F Viruses. 2022; 14(11).
PMID: 36366566 PMC: 9696223. DOI: 10.3390/v14112469.
Recent clinical findings on the role of kinase inhibitors in COVID-19 management.
Malekinejad Z, Baghbanzadeh A, Nakhlband A, Baradaran B, Jafari S, Bagheri Y Life Sci. 2022; 306:120809.
PMID: 35841979 PMC: 9278000. DOI: 10.1016/j.lfs.2022.120809.
Active site prediction of phosphorylated SARS-CoV-2 N-Protein using molecular simulation.
Sankararaman S, Hamre 3rd J, Almsned F, Aljouie A, Bokhari Y, Alawwad M Inform Med Unlocked. 2022; 29:100889.
PMID: 35224174 PMC: 8860464. DOI: 10.1016/j.imu.2022.100889.